Novavax Inc. Stock Rises Tuesday, Outperforms Market

Panasonic Holdings Corp

Change company Symbol lookup

Select an option...

PCRFY Panasonic Holdings Corp

CRTD Creatd Inc

MSM MSC Industrial Direct Co Inc

FGEN FibroGen Inc

SUI Sun Communities Inc

HROWL HARROW HEALTH 8 625 SNR NTS

COF-I Capital One Financial Corp

VRAY ViewRay Inc

PEBC Peoples Bancorp Inc

ACLS Axcelis Technologies Inc

Consumer Discretionary : Household Durables | Large Cap Value
Based in Japan

Company profile

Panasonic Corporation is a Japan-based company engaged in the integrated electronics related business. The Company has four business segments. The Appliance segment is engaged in the development, manufacture and sale of products for home appliance, beauty, health and other business to consumer (BtoC) business, as well as devices, energy and other business to business (BtoB) business. The Eco Solutions segment is engaged in the development, manufacture and sale of electrical equipment, housing materials and other products for construction business. The Connected Solutions segment is engaged in the development, manufacture and sale of products for distribution, logistics, entertainment, public, avionics and manufacturing business. The Automotive and Industrial Systems segment is engaged in the development, manufacture and sale of products for automotive motorized systems business, as well as batteries and other BtoB business. The Company is also engaged in the sale of raw materials.

Novavax Inc. Stock Rises Tuesday, Outperforms Market

5:13 pm ET November 8, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Novavax Inc. (NVAX) advanced 1.13% to $19.65 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.49% to 10,616.20 and the Dow Jones Industrial Average rising 1.02% to 33,160.83. This was the stock's second consecutive day of gains. Novavax Inc. closed $216.85 short of its 52-week high ($236.50), which the company achieved on December 20th.

The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Replimune Group Inc. (REPL) rose 2.38% to $18.04, VBI Vaccines Inc. (VBIV) fell 0.83% to $0.65, and AnaptysBio Inc. (ANAB) rose 1.65% to $29.57. Trading volume (4.5 M) remained 482,689 below its 50-day average volume of 5.0 M.

Data source: Dow Jones Market Data, FactSet. Data compiled November 8, 2022.

(END) Dow Jones Newswires

November 08, 2022 17:13 ET (22:13 GMT)